Spragg, RG;
Lewis, JF;
Walmrath, H-D;
Johannigman, J;
Bellingan, G;
Laterre, P-F;
Witte, MC;
... Seeger, W; + view all
(2004)
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
N Engl J Med
, 351
(9)
pp. 884-892.
10.1056/NEJMoa033181.
![[thumbnail of 8024.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
8024.pdf Download (107kB) |
Abstract
BACKGROUND: Preclinical studies suggest that exogenous surfactant may be of value in the treatment of the acute respiratory distress syndrome (ARDS), and two phase 2 clinical trials have shown a trend toward benefit. We conducted two phase 3 studies of a protein-containing surfactant in adults with ARDS. METHODS: In two multicenter, randomized, double-blind trials involving 448 patients with ARDS from various causes, we compared standard therapy alone with standard therapy plus up to four intratracheal doses of a recombinant surfactant protein C-based surfactant given within a period of 24 hours. RESULTS: The overall survival rate was 66 percent 28 days after treatment, and the median number of ventilator-free days was 0 (68 percent range, 0 to 26); there was no significant difference between the groups in terms of mortality or the need for mechanical ventilation. Patients receiving surfactant had a significantly greater improvement in blood oxygenation during the initial 24 hours of treatment than patients receiving standard therapy, according to both univariate and multivariate analyses. CONCLUSIONS: The use of exogenous surfactant in a heterogeneous population of patients with ARDS did not improve survival. Patients who received surfactant had a greater improvement in gas exchange during the 24-hour treatment period than patients who received standard therapy alone, suggesting the potential benefit of a longer treatment course.
| Type: | Article |
|---|---|
| Title: | Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1056/NEJMoa033181 |
| Keywords: | APACHE, Analysis of Variance, Causality, Double-Blind Method, Female, Humans, Logistic Models, Male, Middle Aged, Oxygen, Pulmonary Surfactant-Associated Protein C, Pulmonary Surfactants, Recombinant Proteins, Respiration, Artificial, Respiratory Distress Syndrome, Survival Rate, Treatment Failure |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/8024 |
Archive Staff Only
 |
View Item |
